Interaction of non-steroidal antiinflammatory agents with corticosterone binding to plasma proteins in the rat.
D000324:Adrenocorticotropic Hormone / Q000494:pharmacology*; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology*; D001798:Blood Proteins; D003345:Corticosterone / Q000032:analysis / Q000097:blood*; D005439:Flufenamic Acid / Q000008:administration & dosage; D007213:Indomethacin / Q000008:administration & dosage; D008297:Male; D008528:Mefenamic Acid / Q000008:administration & dosage; D010113:Oxyphenbutazone / Q000008:administration & dosage; D010653:Phenylbutazone / Q000008:administration & dosage; D010949:Plasma / Q000032:analysis*; D011485:Protein Binding / Q000187:drug effects*; D051381:Rats; D012980:Sodium Salicylate / Q000008:administration & dosage; D013268:Stimulation, Chemical; D013442:Sulfinpyrazone / Q000008:administration & dosage; D014316:Tritium
D000893:Anti-Inflammatory Agents; D001798:Blood Proteins; D014316:Tritium; D008528:Mefenamic Acid; D005439:Flufenamic Acid; D000324:Adrenocorticotropic Hormone; D010653:Phenylbutazone; D010113:Oxyphenbutazone; D013442:Sulfinpyrazone; D003345:Corticosterone; D012980:Sodium Salicylate; D007213:Indomethacin